INSMED INC Cash Equivalents, at Carrying Value
INSMED INC (INSM) had Cash Equivalents, at Carrying Value of $90.78 million as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2013-03-18
- 2012-12-31: Cash Equivalents, at Carrying Value $90.78M.
- 2012-09-30: Cash Equivalents, at Carrying Value $44.99M.
- 2012-06-30: Cash Equivalents, at Carrying Value $28.57M.
- 2012-03-31: Cash Equivalents, at Carrying Value $22.04M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2012-12-31 | $90.78M 10-K · filed 2013-03-18 |
| 2012-09-30 | $44.99M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $28.57M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $22.04M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $14.85M 10-K · filed 2013-03-18 |
| 2011-09-30 | $10.45M 10-Q · filed 2012-11-07 |
| 2011-06-30 | $9.84M 10-Q · filed 2012-08-07 |
| 2011-03-31 | $22.10M 10-Q · filed 2012-05-08 |
| 2010-12-31 | $10.74M 10-K · filed 2013-03-18 |
| 2010-09-30 | $9.69M 10-Q · filed 2011-11-09 |
| 2010-06-30 | $11.32M 10-Q/A · filed 2011-08-08 |
| 2009-12-31 | $12.74M 10-K · filed 2013-03-18 |
| 2008-12-31 | $2.15M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |